CLCD / CoLucid Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

CoLucid Pharmaceuticals, Inc.
US ˙ NASDAQ
HINDI NA ACTIVE ANG SIMBONG ITO

Saham Orang Dalam3,196,211 shares
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

N/A

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

N/A

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan CoLucid Pharmaceuticals, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di CLCD / CoLucid Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2016-09-09 Novo A/S 100,000 20.0000 100,000 20.0000 2,000,000 174
2015-08-25 Mathers Thomas P. 7,500 7.1033 7,500 7.1033 53,275
2015-05-11 Marengere Luc 500,000 10.0000 500,000 10.0000 5,000,000
2015-05-11 Novo A/S 1,300,000 10.0000 1,300,000 10.0000 13,000,000
2015-05-11 PAPPAS ARTHUR M 282,440 10.0000 282,440 10.0000 2,824,400
2015-05-11 PAPPAS ARTHUR M 17,560 10.0000 17,560 10.0000 175,600

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

CLCD / CoLucid Pharmaceuticals, Inc. Insider Trades
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di CLCD / CoLucid Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2017-01-05 Mathers Thomas P. 500 35.6000 500 35.6000 17,800 56
2017-01-05 Mathers Thomas P. 200 34.8625 200 34.8625 6,972
2017-01-05 Mathers Thomas P. 802 34.2462 802 34.2462 27,465
2016-12-05 Mathers Thomas P. 1,502 38.7500 1,502 38.7500 58,202
2016-11-07 Mathers Thomas P. 1,502 28.5732 1,502 28.5732 42,917
2016-10-05 Mathers Thomas P. 1,502 37.0800 1,502 37.0800 55,694
2016-09-07 Mathers Thomas P. 663 20.5555 663 20.5555 13,628
2016-09-07 Mathers Thomas P. 442 23.4267 442 23.4267 10,355
2016-09-07 Mathers Thomas P. 2,633 22.6164 2,633 22.6164 59,549

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

CLCD / CoLucid Pharmaceuticals, Inc. Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas
Tanggal
Perdagangan
Tanggal
Formulir Orang Dalam Ticker Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Unit
Diubah
Nilai
Diubah (1 ribu)
Sisa
Pilihan
Sisa
Saham
2017-03-01 2017-03-01 4 LILLY ELI & CO CLCD Common Stock, par value $0.001 J - Other D 46.5000 19,285,108 896,758 100
2017-03-01 2017-03-01 4 PAPPAS ARTHUR M CLCD Stock Option (Right to Buy) D - Sale to Issuer D 6.24 40.2600 -8,897 -358 0
2017-03-01 2017-03-01 4 PAPPAS ARTHUR M CLCD Stock Option (Right to Buy) D - Sale to Issuer D 10.00 36.5000 -5,954 -217 0
2017-03-01 2017-03-01 4 PAPPAS ARTHUR M By Pappas Capital, LLC CLCD Common Stock U - Other I 46.5000 -5,528 -257 0
2017-03-01 2017-03-01 4 PAPPAS ARTHUR M By PV III CEO Fund, L.P. CLCD Common Stock U - Other I 46.5000 -116,317 -5,409 0
2017-03-01 2017-03-01 4 PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. CLCD Common Stock U - Other I 46.5000 -1,871,049 -87,004 0
2017-03-01 2017-03-01 4 Skwierczynski Raymond CLCD Employee Stock Option (Right to Buy) D - Sale to Issuer D 6.75 39.7500 -15,000 -596 0
2017-03-01 2017-03-01 4 Skwierczynski Raymond CLCD Employee Stock Option (Right to Buy) D - Sale to Issuer D 5.69 40.8100 -90,000 -3,673 0
2017-03-01 2017-03-01 4 Skwierczynski Raymond CLCD Common Stock U - Other D 46.5000 -3,615 -168 0
2017-03-01 2017-03-01 4 White Marvin L CLCD Stock Option (Right to Buy) D - Sale to Issuer D 36.20 10.3000 -453 -5 0
2017-03-01 2017-03-01 4 White Marvin L CLCD Stock Option (Right to Buy) D - Sale to Issuer D 9.62 36.8800 -1,630 -60 0
2017-03-01 2017-03-01 4 White Marvin L CLCD Stock Option (Right to Buy) D - Sale to Issuer D 6.24 40.2600 -8,897 -358 0
2017-03-01 2017-03-01 4 White Marvin L CLCD Stock Option (Right to Buy) D - Sale to Issuer D 8.50 38.0000 -997 -38 0
2017-03-01 2017-03-01 4 White Marvin L CLCD Stock Option (Right to Buy) D - Sale to Issuer D 8.60 37.9000 -6,577 -249 0
2017-03-01 2017-03-01 4 Mathers Thomas P. CLCD Restricted Stock Units D - Sale to Issuer D 46.5000 -105,147 -4,889 0
2017-03-01 2017-03-01 4 Mathers Thomas P. CLCD Employee Stock Option (Right to Buy) D - Sale to Issuer D 6.75 39.7500 -83,000 -3,299 0
2017-03-01 2017-03-01 4 Mathers Thomas P. CLCD Employee Stock Option (Right to Buy) D - Sale to Issuer D 10.00 36.5000 -360,508 -13,159 0
2017-03-01 2017-03-01 4 Mathers Thomas P. CLCD Common Stock D - Sale to Issuer D 46.5000 -83,000 -3,860 0
2017-03-01 2017-03-01 4 Mathers Thomas P. CLCD Common Stock U - Other D 46.5000 -173,519 -8,069 0
2017-03-01 2017-03-01 4 Lawton Alison Frances CLCD Stock Option (Right to Buy) D - Sale to Issuer D 36.20 10.3000 -658 -7 0
2017-03-01 2017-03-01 4 Lawton Alison Frances CLCD Stock Option (Right to Buy) D - Sale to Issuer D 6.24 40.2600 -8,897 -358 0
2017-03-01 2017-03-01 4 Lawton Alison Frances CLCD Stock Option (Right to Buy) D - Sale to Issuer D 6.54 39.9600 -1,420 -57 0
2017-03-01 2017-03-01 4 Marengere Luc CLCD Stock Option (Right to Buy) D - Sale to Issuer D 36.20 10.3000 -658 -7 0
2017-03-01 2017-03-01 4 Marengere Luc CLCD Stock Option (Right to Buy) D - Sale to Issuer D 9.62 36.8800 -2,371 -87 0
2017-03-01 2017-03-01 4 Marengere Luc CLCD Stock Option (Right to Buy) D - Sale to Issuer D 6.24 40.2600 -8,897 -358 0
2017-03-01 2017-03-01 4 Marengere Luc CLCD Stock Option (Right to Buy) D - Sale to Issuer D 8.50 38.0000 -1,449 -55 0
2017-03-01 2017-03-01 4 Marengere Luc CLCD Stock Option (Right to Buy) D - Sale to Issuer D 10.00 36.5000 -5,954 -217 0
2017-03-01 2017-03-01 4 Marengere Luc By TVM Life Science Ventures VII L.P. CLCD Common Stock U - Other I 46.5000 -1,545,386 -71,860 0
2017-03-01 2017-03-01 4 CORRIGAN MARK CLCD Stock Option (Right to Buy) D - Sale to Issuer D 6.24 40.2600 -8,897 -358 0
2017-03-01 2017-03-01 4 CORRIGAN MARK CLCD Stock Option (Right to Buy) D - Sale to Issuer D 3.79 42.7100 -8,114 -347 0
2017-03-01 2017-03-01 4 Dallas Matthew D CLCD Employee Stock Option (Right to Buy) D - Sale to Issuer D 6.75 39.7500 -37,500 -1,491 0
2017-03-01 2017-03-01 4 Dallas Matthew D CLCD Employee Stock Option (Right to Buy) D - Sale to Issuer D 7.56 38.9400 -30,000 -1,168 0
2017-03-01 2017-03-01 4 Dallas Matthew D CLCD Employee Stock Option (Right to Buy) D - Sale to Issuer D 10.00 36.5000 -180,254 -6,579 0
2017-03-01 2017-03-01 4 Dallas Matthew D CLCD Common Stock D - Sale to Issuer D 46.5000 -37,500 -1,744 0
2017-03-01 2017-03-01 4 Dallas Matthew D CLCD Common Stock U - Other D 46.5000 -2,708 -126 0
2017-03-01 2017-03-01 4 Hogan Linda C. CLCD Stock Option (Right to Buy) D - Sale to Issuer D 6.75 39.7500 -26,594 -1,057 0
2017-03-01 2017-03-01 4 Hogan Linda C. CLCD Stock Option (Right to Buy) D - Sale to Issuer D 7.56 38.9400 -5,741 -224 0
2017-03-01 2017-03-01 4 Hogan Linda C. CLCD Stock Option (Right to Buy) D - Sale to Issuer D 10.00 36.5000 -46,966 -1,714 0
2017-03-01 2017-03-01 4 Kuca Bernice CLCD Employee Stock Option (right to buy) D - Sale to Issuer D 6.75 39.7500 -37,500 -1,491 0
2017-03-01 2017-03-01 4 Kuca Bernice CLCD Employee Stock Option (right to buy) D - Sale to Issuer D 10.00 36.5000 -270,381 -9,869 0
2017-03-01 2017-03-01 4 Kuca Bernice CLCD Common Stock D - Sale to Issuer D 46.5000 -37,500 -1,744 0
2017-03-01 2017-03-01 4 Kuca Bernice CLCD Common Stock U - Other D 46.5000 -2,729 -127 0
2017-01-27 3 ProCar Acquisition Corp CLCD Common stock D 109,366
2017-01-27 3 ProCar Acquisition Corp CLCD Common stock D 109,366
2017-01-27 3 ProCar Acquisition Corp CLCD Common stock D 109,366
2017-01-05 2017-01-05 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 10.00 -1,677 46,966
2017-01-05 2017-01-05 4 Hogan Linda C. CLCD Common Stock S - Sale D 35.6083 -600 -21 0
2017-01-05 2017-01-05 4 Hogan Linda C. CLCD Common Stock S - Sale D 34.4000 -600 -21 600
2017-01-05 2017-01-05 4 Hogan Linda C. CLCD Common Stock S - Sale D 33.5548 -477 -16 1,200
2017-01-05 2017-01-05 4 Hogan Linda C. CLCD Common Stock M - Exercise D 10.0000 1,677 17 1,677
2017-01-05 2017-01-04 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 7.56 -185 5,741
2017-01-05 2017-01-04 4 Hogan Linda C. CLCD Common Stock S - Sale D 36.4000 -185 -7 0
2017-01-05 2017-01-04 4 Hogan Linda C. CLCD Common Stock M - Exercise D 7.5600 185 1 185
2017-01-05 2017-01-03 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 6.75 -718 26,594
2017-01-05 2017-01-03 4 Hogan Linda C. CLCD Common Stock S - Sale D 36.2500 -718 -26 0
2017-01-05 2017-01-03 4 Hogan Linda C. CLCD Common Stock M - Exercise D 6.7500 718 5 718
2017-01-05 2017-01-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -3,755 105,147
2017-01-05 2017-01-05 4 Mathers Thomas P. CLCD Common Stock S - Sale D 35.6000 -500 -18 256,519
2017-01-05 2017-01-05 4 Mathers Thomas P. CLCD Common Stock S - Sale D 34.8625 -200 -7 257,019
2017-01-05 2017-01-05 4 Mathers Thomas P. CLCD Common Stock S - Sale D 34.2462 -802 -27 257,219
2017-01-05 2017-01-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 3,755 258,021
2017-01-04 2017-01-03 4 White Marvin L CLCD Stock Option (Right to Buy) A - Award D 36.20 30.3500 453 14 453
2017-01-04 2017-01-03 4 Lawton Alison Frances CLCD Stock Option (Right to Buy) A - Award D 36.20 30.4000 658 20 658
2017-01-04 2017-01-03 4 Dallas Matthew D CLCD Common Stock S - Sale D 36.2500 -1,473 -53 40,128
2017-01-04 2017-01-03 4 Marengere Luc CLCD Stock Option (Right to Buy) A - Award D 36.20 30.4000 658 20 658
2017-01-04 2017-01-03 4 Kuca Bernice CLCD Common Stock S - Sale D 36.2500 -772 -28 40,086
2016-12-05 2016-12-05 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 10.00 -1,678 48,643
2016-12-05 2016-12-05 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 7.56 -186 5,926
2016-12-05 2016-12-05 4 Hogan Linda C. CLCD Common Stock S - Sale D 38.7500 -1,678 -65 0
2016-12-05 2016-12-05 4 Hogan Linda C. CLCD Common Stock M - Exercise D 10.0000 1,678 17 1,678
2016-12-05 2016-12-05 4 Hogan Linda C. CLCD Common Stock S - Sale D 38.7500 -186 -7 0
2016-12-05 2016-12-05 4 Hogan Linda C. CLCD Common Stock M - Exercise D 7.5600 186 1 186
2016-12-05 2016-12-01 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 6.75 -719 27,312
2016-12-05 2016-12-01 4 Hogan Linda C. CLCD Common Stock S - Sale D 35.2191 -719 -25 0
2016-12-05 2016-12-01 4 Hogan Linda C. CLCD Common Stock M - Exercise D 6.7500 719 5 719
2016-12-05 2016-12-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -3,756 108,902
2016-12-05 2016-12-05 4 Mathers Thomas P. CLCD Common Stock S - Sale D 38.7500 -1,502 -58 254,266
2016-12-05 2016-12-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 3,756 255,768
2016-12-01 2016-12-01 4 Dallas Matthew D CLCD Common Stock S - Sale D 35.1671 -1,473 -52 41,601
2016-12-01 2016-12-01 4 Kuca Bernice CLCD Common Stock S - Sale D 35.2202 -772 -27 40,858
2016-11-07 2016-11-07 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 10.00 -1,677 50,321
2016-11-07 2016-11-07 4 Hogan Linda C. CLCD Common Stock S - Sale D 28.5212 -1,677 -48 0
2016-11-07 2016-11-07 4 Hogan Linda C. CLCD Common Stock M - Exercise D 10.0000 1,677 17 1,677
2016-11-07 2016-11-04 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 7.56 -185 6,112
2016-11-07 2016-11-04 4 Hogan Linda C. CLCD Common Stock S - Sale D 28.9500 -185 -5 0
2016-11-07 2016-11-04 4 Hogan Linda C. CLCD Common Stock M - Exercise D 7.5600 185 1 185
2016-11-07 2016-11-07 4 Mathers Thomas P. CLCD Common Stock S - Sale D 28.5732 -1,502 -43 248,920
2016-11-07 2016-11-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -3,755 112,658
2016-11-07 2016-11-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 3,755 250,422
2016-11-01 2016-11-01 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 6.75 -719 28,031
2016-11-01 2016-11-01 4 Hogan Linda C. CLCD Common Stock S - Sale D 30.0000 -719 -22 0
2016-11-01 2016-11-01 4 Hogan Linda C. CLCD Common Stock M - Exercise D 6.7500 719 5 719
2016-10-05 2016-10-05 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 10.00 -1,677 51,998
2016-10-05 2016-10-05 4 Hogan Linda C. CLCD Common Stock S - Sale D 37.0800 -1,677 -62 0
2016-10-05 2016-10-05 4 Hogan Linda C. CLCD Common Stock M - Exercise D 10.0000 1,677 17 1,677
2016-10-05 2016-10-04 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 7.56 -185 6,297
2016-10-05 2016-10-04 4 Hogan Linda C. CLCD Common Stock S - Sale D 36.4100 -185 -7 0
2016-10-05 2016-10-04 4 Hogan Linda C. CLCD Common Stock M - Exercise D 7.5600 185 1 185
2016-10-05 2016-10-03 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 6.75 -719 28,750
2016-10-05 2016-10-03 4 Hogan Linda C. CLCD Common Stock S - Sale D 37.7400 -719 -27 0
2016-10-05 2016-10-03 4 Hogan Linda C. CLCD Common Stock M - Exercise D 6.7500 719 5 719
2016-10-05 2016-10-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -3,755 116,413
2016-10-05 2016-10-05 4 Mathers Thomas P. CLCD Common Stock S - Sale D 37.0800 -1,502 -56 246,667
2016-10-05 2016-10-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 3,755 248,169
2016-09-16 2016-09-14 4 Mathers Thomas P. CLCD Common Stock S - Sale D 23.7800 -300 -7 244,414
2016-09-16 2016-09-14 4 Mathers Thomas P. CLCD Common Stock S - Sale D 23.3004 -5,700 -133 244,714
2016-09-13 2016-09-09 4 Domain Partners VI, L.P. CLCD Common Stock J - Other D -1,943,109 0
2016-09-13 2016-09-09 4 Novo A/S CLCD COMMON STOCK P - Purchase D 20.0000 100,000 2,000 3,156,563
2016-09-07 2016-09-06 4 Hogan Linda C. By LLH Associates, LLC CLCD Stock Option (Right to Buy) M - Exercise I 5.09 -896 0
2016-09-07 2016-09-06 4 Hogan Linda C. By LLH Associates, LLC CLCD Stock Option (Right to Buy) M - Exercise I 5.09 -2,839 0
2016-09-07 2016-09-06 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 6.75 -5,031 29,469
2016-09-07 2016-09-06 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 7.56 -3,518 6,482
2016-09-07 2016-09-06 4 Hogan Linda C. CLCD Stock Option (Right to Buy) M - Exercise D 10.00 -36,452 53,675
2016-09-07 2016-09-06 4 Hogan Linda C. By LLH Associates, LLC CLCD Common Stock S - Sale I 19.5000 -3,735 -73 0
2016-09-07 2016-09-06 4 Hogan Linda C. By LLH Associates, LLC CLCD Common Stock M - Exercise I 5.0900 896 5 3,735
2016-09-07 2016-09-06 4 Hogan Linda C. By LLH Associates, LLC CLCD Common Stock M - Exercise I 5.0900 2,839 14 2,839
2016-09-07 2016-09-06 4 Hogan Linda C. CLCD Common Stock S - Sale D 20.0011 -31,420 -628 0
2016-09-07 2016-09-06 4 Hogan Linda C. CLCD Common Stock S - Sale D 20.0000 -5,032 -101 31,420
2016-09-07 2016-09-06 4 Hogan Linda C. CLCD Common Stock S - Sale D 19.5000 -8,549 -167 36,452
2016-09-07 2016-09-06 4 Hogan Linda C. CLCD Common Stock M - Exercise D 6.7500 5,031 34 45,001
2016-09-07 2016-09-06 4 Hogan Linda C. CLCD Common Stock M - Exercise D 7.5600 3,518 27 39,970
2016-09-07 2016-09-06 4 Hogan Linda C. CLCD Common Stock M - Exercise D 10.0000 36,452 365 36,452
2016-09-07 2016-09-07 4 Mathers Thomas P. CLCD Common Stock S - Sale D 24.3967 -300 -7 250,414
2016-09-07 2016-09-07 4 Mathers Thomas P. CLCD Common Stock S - Sale D 23.4267 -442 -10 250,714
2016-09-07 2016-09-07 4 Mathers Thomas P. CLCD Common Stock S - Sale D 22.6164 -2,633 -60 251,156
2016-09-07 2016-09-07 4 Mathers Thomas P. CLCD Common Stock S - Sale D 21.9045 -962 -21 253,789
2016-09-07 2016-09-07 4 Mathers Thomas P. CLCD Common Stock S - Sale D 20.5555 -663 -14 254,751
2016-09-07 2016-09-06 4 Mathers Thomas P. CLCD Common Stock S - Sale D 19.5000 -1,502 -29 255,414
2016-09-07 2016-09-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -3,756 120,168
2016-09-07 2016-09-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 3,756 256,916
2016-08-31 2016-08-31 4 Skwierczynski Raymond CLCD Common Stock S - Sale D 10.8600 -150 -2 47
2016-08-19 2016-08-19 4 Skwierczynski Raymond CLCD Common Stock S - Sale D 8.4100 -508 -4 197
2016-08-10 2016-08-10 4 Skwierczynski Raymond CLCD Common Stock S - Sale D 8.3000 -508 -4 705
2016-08-05 2016-08-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -3,755 123,924
2016-08-05 2016-08-05 4 Mathers Thomas P. CLCD Common Stock S - Sale D 8.3100 -1,502 -12 253,160
2016-08-05 2016-08-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 3,755 254,662
2016-08-03 2016-08-03 4 Domain Partners VI, L.P. CLCD Common Stock S - Sale D 8.1500 -81,094 -661 1,943,109
2016-08-03 2016-08-02 4 Domain Partners VI, L.P. CLCD Common Stock S - Sale D 8.7100 -19,718 -172 2,024,203
2016-08-03 2016-08-01 4 Domain Partners VI, L.P. CLCD Common Stock S - Sale D 8.8200 -52,216 -461 2,043,921
2016-08-03 2016-08-03 4 DP VI Associates, L.P. CLCD Common Stock S - Sale D 8.1500 -129 -1 3,039
2016-08-03 2016-08-02 4 DP VI Associates, L.P. CLCD Common Stock S - Sale D 8.7100 -32 -0 3,168
2016-08-03 2016-08-01 4 DP VI Associates, L.P. CLCD Common Stock S - Sale D 8.8200 -84 -1 3,200
2016-07-29 2016-07-29 4 Skwierczynski Raymond CLCD Common Stock S - Sale D 9.0850 -508 -5 1,213
2016-07-20 2016-07-20 4 Skwierczynski Raymond CLCD Common Stock S - Sale D 8.9700 -508 -5 1,721
2016-07-12 2016-07-11 4 Skwierczynski Raymond CLCD Common Stock S - Sale D 9.1000 -508 -5 2,229
2016-07-05 2016-07-01 4 White Marvin L CLCD Stock Option (Right to Buy) A - Award D 9.62 8.4400 1,630 14 1,630
2016-07-05 2016-07-01 4 Marengere Luc CLCD Stock Option (Right to Buy) A - Award D 9.62 8.4400 2,371 20 2,371
2016-07-05 2016-07-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -3,755 127,679
2016-07-05 2016-07-05 4 Mathers Thomas P. CLCD Common Stock S - Sale D 9.7300 -1,502 -15 250,907
2016-07-05 2016-07-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 3,755 252,409
2016-06-30 2016-06-30 4 Skwierczynski Raymond CLCD Common Stock S - Sale D 7.0110 -516 -4 2,737
2016-06-22 2016-06-20 4 Skwierczynski Raymond CLCD Common Stock S - Sale D 7.0000 -500 -4 3,253
2016-06-22 2016-06-10 4 Skwierczynski Raymond CLCD Common Stock S - Sale D 6.5984 -508 -3 3,753
2016-06-07 2016-06-06 4 Mathers Thomas P. CLCD Common Stock S - Sale D 7.2463 -1,502 -11 248,654
2016-06-07 2016-06-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -3,756 131,434
2016-06-07 2016-06-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 3,756 250,156
2016-05-12 2016-05-10 4 CORRIGAN MARK CLCD Stock Option (Right to Buy) A - Award D 6.24 8,897 8,897
2016-05-12 2016-05-10 4 PAPPAS ARTHUR M CLCD Stock Option (Right to Buy) A - Award D 6.24 8,897 8,897
2016-05-12 2016-05-10 4 White Marvin L CLCD Stock Option (Right to Buy) A - Award D 6.24 8,897 8,897
2016-05-12 2016-05-10 4 Lawton Alison Frances CLCD Stock Option (Right to Buy) A - Award D 6.24 8,897 8,897
2016-05-12 2016-05-10 4 Marengere Luc CLCD Stock Option (Right to Buy) A - Award D 6.24 8,897 8,897
2016-05-09 2016-05-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -45,064 135,190
2016-05-09 2016-05-05 4 Mathers Thomas P. CLCD Common Stock F - Taxes D 6.4900 -14,624 -95 241,400
2016-05-09 2016-05-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 45,064 256,024
2016-05-02 2016-04-28 4 DP VI Associates, L.P. CLCD Common Stock S - Sale D 6.9600 -235 -2 3,284
2016-05-02 2016-04-28 4 Domain Partners VI, L.P. CLCD Common Stock S - Sale D 6.9600 -149,765 -1,042 2,096,137
2016-03-15 2016-03-11 4 Lawton Alison Frances CLCD Stock Option (Right to Buy) A - Award D 6.54 1,420 1,420
2016-03-07 2016-03-04 4 Dallas Matthew D CLCD Employee Stock Option (Right to Buy) A - Award D 6.75 37,500 37,500
2016-03-07 2016-03-04 4 Dallas Matthew D CLCD Common Stock A - Award D 37,500 37,500
2016-03-07 2016-03-04 4 Hogan Linda C. CLCD Stock Option (Right to Buy) A - Award D 6.75 34,500 34,500
2016-03-07 2016-03-04 4 Kuca Bernice CLCD Employee Stock Option (Right to Buy) A - Award D 6.75 37,500 37,500
2016-03-07 2016-03-04 4 Kuca Bernice CLCD Common Stock A - Award D 37,500 37,500
2016-03-07 2016-03-04 4 Mathers Thomas P. CLCD Employee Stock Option (Right to Buy) A - Award D 6.75 83,000 83,000
2016-03-07 2016-03-04 4 Mathers Thomas P. CLCD Common Stock A - Award D 83,000 210,960
2016-03-07 2016-03-04 4 Skwierczynski Raymond CLCD Employee Stock Option (Right to Buy) A - Award D 6.75 15,000 15,000
2016-01-06 2016-01-04 4 White Marvin L CLCD Stock Option (Right to Buy) A - Award D 8.50 6.9000 997 7 997
2016-01-06 2016-01-04 4 Marengere Luc CLCD Stock Option (Right to Buy) A - Award D 8.50 6.9000 1,449 10 1,449
2015-12-02 2015-11-30 4 Skwierczynski Raymond CLCD Employee Stock Option (Right to Buy) A - Award D 5.69 90,000 90,000
2015-11-06 2015-11-05 4 Mathers Thomas P. CLCD Restricted Stock Units M - Exercise D -180,254 180,254
2015-11-06 2015-11-05 4 Mathers Thomas P. CLCD Common Stock F - Taxes D 4.5800 -59,794 -274 127,960
2015-11-06 2015-11-05 4 Mathers Thomas P. CLCD Common Stock M - Exercise D 180,254 187,754
2015-10-29 2015-10-27 4 CORRIGAN MARK CLCD Stock Option (Right to Buy) A - Award D 3.79 8,114 8,114
2015-08-25 2015-08-25 4 Mathers Thomas P. CLCD Common Stock P - Purchase D 7.1033 7,500 53 7,500
2015-08-06 2015-08-04 4 Hogan Linda C. CLCD Stock Option (Right to Buy) A - Award D 7.56 10,000 10,000
2015-08-06 2015-08-04 4 Dallas Matthew D CLCD Employee Stock Option (Right to Buy) A - Award D 7.56 30,000 30,000
2015-07-13 2015-07-09 4 White Marvin L CLCD Stock Option (Right to Buy) A - Award D 8.60 6,577 6,577
2015-05-13 2015-05-13 4 Rupniak Nadia CLCD Employee Stock Option (Right to Buy) M - Exercise D 5.09 -3,690 0
2015-05-13 2015-05-13 4 Rupniak Nadia CLCD Employee Stock Option (Right to Buy) M - Exercise D 5.09 -5,541 0
2015-05-13 2015-05-13 4 Rupniak Nadia CLCD Employee Stock Option (Right to Buy) M - Exercise D 4.07 -2,457 0
2015-05-13 2015-05-13 4 Rupniak Nadia CLCD Employee Stock Option (Right to Buy) M - Exercise D 4.07 -2,457 0
2015-05-13 2015-05-13 4 Rupniak Nadia CLCD Common Stock M - Exercise D 5.0900 3,690 19 14,145
2015-05-13 2015-05-13 4 Rupniak Nadia CLCD Common Stock M - Exercise D 5.0900 5,541 28 10,455
2015-05-13 2015-05-13 4 Rupniak Nadia CLCD Common Stock M - Exercise D 4.0700 2,457 10 4,914
2015-05-13 2015-05-13 4 Rupniak Nadia CLCD Common Stock M - Exercise D 4.0700 2,457 10 4,914
2015-05-12 2015-05-11 4 Novo A/S CLCD SERIES C PREFERRED STOCK C - Conversion D -1,756,563 0
2015-05-12 2015-05-11 4 Novo A/S CLCD COMMON STOCK P - Purchase D 10.0000 1,300,000 13,000 3,056,563
2015-05-12 2015-05-11 4 Novo A/S CLCD COMMON STOCK C - Conversion D 1,756,563 1,756,563
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By PV III CEO Fund, L.P. CLCD Series C Convertible Preferred Stock C - Conversion I -20,808 0
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. CLCD Series C Convertible Preferred Stock C - Conversion I -334,722 0
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By PV III CEO Fund, L.P. CLCD Series B Convertible Preferred Stock C - Conversion I -41,996 0
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. CLCD Series B Convertible Preferred Stock C - Conversion I -675,588 0
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By PV III CEO Fund, L.P. CLCD Series A Convertible Preferred Stock C - Conversion I -35,953 0
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. CLCD Series A Convertible Preferred Stock C - Conversion I -578,297 0
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By PV III CEO Fund, L.P. CLCD Common Stock P - Purchase I 10.0000 17,560 176 116,317
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. CLCD Common Stock P - Purchase I 10.0000 282,440 2,824 1,871,049
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By PV III CEO Fund, L.P. CLCD Common Stock C - Conversion I 98,757 98,757
2015-05-12 2015-05-11 4 PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. CLCD Common Stock C - Conversion I 1,588,607 1,588,609
2015-05-12 2015-05-11 4 Markham Richard J By Care Capital Offshore Investments III, LP CLCD Series C Convertible Preferred Stock C - Conversion I -5,353 0
2015-05-12 2015-05-11 4 Markham Richard J By Care Capital Investments III, LP CLCD Series C Convertible Preferred Stock C - Conversion I -320,295 0
2015-05-12 2015-05-11 4 Markham Richard J By Care Capital Offshore Investments III, LP CLCD Series B Convertible Preferred Stock C - Conversion I -20,050 0
2015-05-12 2015-05-11 4 Markham Richard J By Care Capital Investments III, LP CLCD Series B Convertible Preferred Stock C - Conversion I -1,199,841 0
2015-05-12 2015-05-11 4 Markham Richard J By Care Capital Offshore Investments III, LP CLCD Common Stock C - Conversion I 25,403 25,403
2015-05-12 2015-05-11 4 Markham Richard J By Care Capital Investments III, LP CLCD Common Stock C - Conversion I 1,520,136 1,520,136
2015-05-12 2015-05-11 4 Marengere Luc By TVM Life Science Ventures VII L.P. CLCD Series C Convertible Preferred Stock C - Conversion I -995,386 0
2015-05-12 2015-05-11 4 Marengere Luc By TVM Life Science Ventures VII L.P. CLCD Common Stock P - Purchase I 10.0000 500,000 5,000 1,495,386
2015-05-12 2015-05-11 4 Marengere Luc By TVM Life Science Ventures VII L.P. CLCD Common Stock C - Conversion I 995,386 995,386
2015-05-11 2015-05-11 4 Domain Partners VI, L.P. CLCD Series C Preferred Stock C - Conversion D -464,756 0
2015-05-11 2015-05-11 4 Domain Partners VI, L.P. CLCD Series B Preferred Stock C - Conversion D -939,289 0
2015-05-11 2015-05-11 4 Domain Partners VI, L.P. CLCD Series A Preferred Stock C - Conversion D -798,188 0
2015-05-11 2015-05-11 4 Domain Partners VI, L.P. CLCD Common Stock C - Conversion D 2,202,233 2,245,902
2015-05-11 2015-05-11 4 DP VI Associates, L.P. CLCD Series B Preferred Stock C - Conversion D -1,565 0
2015-05-11 2015-05-11 4 DP VI Associates, L.P. CLCD Series A Preferred Stock C - Conversion D -1,954 0
2015-05-11 2015-05-11 4 DP VI Associates, L.P. CLCD Common Stock C - Conversion D 3,519 3,519
2015-05-07 2015-05-05 4 TREU JESSE I CLCD Stock Option (Right to Buy) A - Award D 10.00 5,954 5,954
2015-05-07 2015-05-05 4 PAPPAS ARTHUR M CLCD Stock Option (Right to Buy) A - Award D 10.00 5,954 5,954
2015-05-07 2015-03-23 4 PAPPAS ARTHUR M By A.M. Pappas & Associates, LLC CLCD Stock Option (Right to Buy) M - Exercise I 4.07 -5,528 0
2015-05-07 2015-03-23 4 PAPPAS ARTHUR M By A.M. Pappas & Associates, LLC CLCD Common Stock M - Exercise I 4.0700 5,528 22 5,528
2015-05-07 2015-01-12 4 PAPPAS ARTHUR M By PV III CEO Fund, L.P. CLCD Series C Convertible Preferred Stock P - Purchase I 20,808 20,808
2015-05-07 2015-01-12 4 PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. CLCD Series C Convertible Preferred Stock P - Purchase I 334,722 334,722
2015-05-07 2015-01-12 4 PAPPAS ARTHUR M By PV III CEO Fund, L.P. CLCD Series B Convertible Preferred Stock P - Purchase I 33,597 33,597
2015-05-07 2015-01-12 4 PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. CLCD Series B Convertible Preferred Stock P - Purchase I 540,470 540,470
2015-05-07 2015-01-12 4 PAPPAS ARTHUR M By PV III CEO Fund, L.P. CLCD Series A Convertible Preferred Stock P - Purchase I 28,763 28,763
2015-05-07 2015-01-12 4 PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P. CLCD Series A Convertible Preferred Stock P - Purchase I 462,637 462,637
2015-05-07 2015-05-05 4 Markham Richard J CLCD Stock Option (Right to Buy) A - Award D 10.00 5,954 5,954
2015-05-07 2015-01-12 4 Markham Richard J By Care Capital Offshore Investments III, LP CLCD Series C Convertible Preferred Stock P - Purchase I 5,353 5,353
2015-05-07 2015-01-12 4 Markham Richard J By Care Capital Investments III, LP CLCD Series C Convertible Preferred Stock P - Purchase I 320,295 320,295
2015-05-07 2015-01-12 4 Markham Richard J By Care Capital Offshore Investments III, LP CLCD Series B Convertible Preferred Stock P - Purchase I 16,041 16,041
2015-05-07 2015-01-12 4 Markham Richard J By Care Capital Investments III, LP CLCD Series B Convertible Preferred Stock P - Purchase I 959,872 959,872
2015-05-07 2015-05-05 4 Dallas Matthew D CLCD Employee Stock Option (Right to Buy) A - Award D 10.00 180,254 180,254
2015-05-07 2015-05-05 4 Hogan Linda C. CLCD Stock Option (Right to Buy) A - Award D 10.00 90,127 90,127
2015-05-07 2015-05-05 4 Rupniak Nadia CLCD Employee Stock Option (Right to Buy) A - Award D 10.00 135,190 135,190
2015-05-07 2015-05-05 4 Kuca Bernice CLCD Employee Stock Option (Right to Buy) A - Award D 10.00 270,381 270,381
2015-05-07 2015-05-05 4 Mathers Thomas P. CLCD Employee Stock Option (Right to Buy) A - Award D 10.00 360,508 360,508
2015-05-07 2015-05-05 4 Mathers Thomas P. CLCD Restricted Stock Units A - Award D 360,508 360,508
2015-05-07 2015-05-05 4 Marengere Luc CLCD Stock Option (Right to Buy) A - Award D 10.00 5,954 5,954
2015-05-07 2015-01-12 4 Marengere Luc By TVM Life Science Ventures VII L.P. CLCD Series C Convertible Preferred Stock P - Purchase I 995,386 995,386
2015-05-05 3 VITULLO NICOLE CLCD Common Stock D 87,338
2015-05-05 3 VITULLO NICOLE CLCD Common Stock D 87,338
2015-05-05 3 VITULLO NICOLE CLCD Common Stock D 87,338
2015-05-05 3 VITULLO NICOLE CLCD Common Stock D 87,338
2015-05-05 3 VITULLO NICOLE CLCD Common Stock D 87,338
2015-05-05 3 VITULLO NICOLE CLCD Common Stock D 87,338
2015-05-05 3 VITULLO NICOLE CLCD Common Stock D 87,338
2015-05-05 3 PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC CLCD Common Stock I 11,058
2015-05-05 3 PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. CLCD Common Stock I 5,532
2015-05-05 3 PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. CLCD Common Stock I 5,532
2015-05-05 3 PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC CLCD Common Stock I 11,058
2015-05-05 3 PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. CLCD Common Stock I 5,532
2015-05-05 3 PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC CLCD Common Stock I 11,058
2015-05-05 3 PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC CLCD Common Stock I 11,058
2015-05-05 3 PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. CLCD Common Stock I 5,532
2015-05-05 3 PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC CLCD Common Stock I 11,058
2015-05-05 3 PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P. CLCD Common Stock I 5,532
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista